Emergent BioSolutions Inc
EBS10.920USD
+0.380+3.61%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
575.48M시가총액
7.68P/E TTM
자세한 내용은 Emergent BioSolutions Inc 회사
Emergent BioSolutions, Inc. is a life sciences company. It is focused on providing preparedness and response solutions addressing accidental, deliberate and naturally occurring public health threats. Its solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing services portfolio. Its segments include Commercial Products, MCM Products, and Services segment. Its Commercial Product segment consists of NARCAN Nasal Spray. Its MCM Products segment consists of Anthrax MCM products, Smallpox MCM products and Other Products. Its Services segment consists of its Bioservices portfolio. NARCAN (naloxone HCl) Nasal Spray, an intranasal formulation of naloxone, is developed for the emergency treatment of known or suspected opioid overdose as manifested by respiratory and central nervous system depression. Its Bioservices consist of development services, bulk drug substance manufacturing, fill, finish, and packaging of final drug products.
Emergent BioSolutions Inc 정보
종목 코드 EBS
회사 이름Emergent BioSolutions Inc
상장일Nov 15, 2006
CEOPapa (Joseph C)
직원 수900
유형Ordinary Share
회계 연도 종료Nov 15
주소300 Professional Dr
도시GAITHERSBURG
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가United States of America
우편 번호20879
전화12406313200
웹사이트https://emergentbiosolutions.com/
종목 코드 EBS
상장일Nov 15, 2006
CEOPapa (Joseph C)
Emergent BioSolutions Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+60000.00%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
196.50K
-4995.00%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+34403.00%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
90.86K
-30608.00%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
88.44K
-3543.00%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
78.17K
-7100.00%
Ms. Jessica Perl
Ms. Jessica Perl
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
68.39K
+62500.00%
Mr. Marvin L. White
Mr. Marvin L. White
Independent Director
Independent Director
68.25K
+34403.00%
Mr. Keith A. Katkin, CPA
Mr. Keith A. Katkin, CPA
Independent Director
Independent Director
66.14K
-7844.00%
Mr. William Hartzel
Mr. William Hartzel
Senior Vice President - Manufacturing and Bioservices
Senior Vice President - Manufacturing and Bioservices
62.55K
-610.00%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Joseph C. (Joe) Papa
Mr. Joseph C. (Joe) Papa
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
342.50K
+60000.00%
Mr. Richard S. (Rich) Lindahl
Mr. Richard S. (Rich) Lindahl
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
196.50K
-4995.00%
Dr. Zsolt Harsanyi, Ph.D.
Dr. Zsolt Harsanyi, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
103.49K
+34403.00%
Ms. Coleen Glessner
Ms. Coleen Glessner
Executive Vice President - Quality and Ethics and Compliance
Executive Vice President - Quality and Ethics and Compliance
90.86K
-30608.00%
Dr. Simon C Lowry, M.D.
Dr. Simon C Lowry, M.D.
Chief Medical Officer, Head of Research and Development
Chief Medical Officer, Head of Research and Development
88.44K
-3543.00%
Mr. Ronald B. Richard
Mr. Ronald B. Richard
Independent Director
Independent Director
78.17K
-7100.00%
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
MCM Product sales
142.50M
61.66%
Commercial Product sales
74.90M
32.41%
Contracts and grants
13.70M
5.93%
지역별USD
이름
수익
비율
U.S.Government
133.00M
57.55%
Non-U.S Government
98.10M
42.45%
사업별
지역별
사업별USD
이름
수익
비율
MCM Product sales
142.50M
61.66%
Commercial Product sales
74.90M
32.41%
Contracts and grants
13.70M
5.93%
주식 보유 통계
마지막 업데이트: Mon, Nov 17
마지막 업데이트: Mon, Nov 17
주주
주주 유형
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
7.43%
The Vanguard Group, Inc.
6.77%
State Street Investment Management (US)
4.66%
American Century Investment Management, Inc.
4.54%
Dimensional Fund Advisors, L.P.
4.08%
기타
72.53%
주주
주주
비율
BlackRock Institutional Trust Company, N.A.
7.43%
The Vanguard Group, Inc.
6.77%
State Street Investment Management (US)
4.66%
American Century Investment Management, Inc.
4.54%
Dimensional Fund Advisors, L.P.
4.08%
기타
72.53%
주주 유형
주주
비율
Investment Advisor
35.43%
Investment Advisor/Hedge Fund
30.46%
Hedge Fund
7.40%
Individual Investor
2.97%
Research Firm
1.57%
Pension Fund
1.05%
Bank and Trust
0.60%
Sovereign Wealth Fund
0.18%
Family Office
0.07%
기타
20.27%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
378
39.86M
83.14%
+128.30K
2025Q3
417
39.73M
84.87%
+2.04M
2025Q2
439
37.58M
87.40%
+1.14M
2025Q1
454
36.44M
84.55%
-9.64M
2024Q4
461
35.04M
82.31%
+2.84M
2024Q3
467
32.21M
81.37%
+1.29M
2024Q2
485
30.86M
99.60%
-5.54M
2024Q1
494
36.44M
103.37%
-17.72M
2023Q4
512
41.89M
103.68%
-1.06M
2023Q3
563
42.52M
113.85%
-6.21M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
BlackRock Institutional Trust Company, N.A.
3.90M
7.43%
+75.52K
+1.97%
Sep 30, 2025
The Vanguard Group, Inc.
3.54M
6.74%
-43.54K
-1.21%
Sep 30, 2025
State Street Investment Management (US)
2.45M
4.66%
+705.00K
+40.50%
Sep 30, 2025
American Century Investment Management, Inc.
2.38M
4.54%
+90.22K
+3.94%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
2.14M
4.08%
+291.31K
+15.75%
Sep 30, 2025
Palisade Capital Management, LLC
1.43M
2.72%
+326.26K
+29.67%
Sep 30, 2025
Charles Schwab Investment Management, Inc.
1.38M
2.63%
+276.57K
+25.02%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.28M
2.43%
-305.00
-0.02%
Sep 30, 2025
Acadian Asset Management LLC
1.18M
2.24%
+203.07K
+20.84%
Sep 30, 2025
Connor, Clark & Lunn Investment Management Ltd.
1.13M
2.16%
+145.63K
+14.76%
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
AdvisorShares Insider Advantage ETF
0.97%
Royce Quant Small-Cap Quality Value ETF
0.41%
State Street SPDR S&P Biotech ETF
0.28%
Federated Hermes MDT Small Cap Core ETF
0.23%
Harbor Human Capital Factor US Small Cap ETF
0.19%
Direxion Daily S&P Biotech Bull 3X Shares
0.18%
Pacer US Small Cap Cash Cows ETF
0.16%
Invesco RAFI US 1500 Small-Mid ETF
0.15%
Avantis US Small Cap Value ETF
0.14%
iShares Micro-Cap ETF
0.13%
더 보기
AdvisorShares Insider Advantage ETF
비율0.97%
Royce Quant Small-Cap Quality Value ETF
비율0.41%
State Street SPDR S&P Biotech ETF
비율0.28%
Federated Hermes MDT Small Cap Core ETF
비율0.23%
Harbor Human Capital Factor US Small Cap ETF
비율0.19%
Direxion Daily S&P Biotech Bull 3X Shares
비율0.18%
Pacer US Small Cap Cash Cows ETF
비율0.16%
Invesco RAFI US 1500 Small-Mid ETF
비율0.15%
Avantis US Small Cap Value ETF
비율0.14%
iShares Micro-Cap ETF
비율0.13%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
데이터 없음
날짜
배당락일
유형
비율
데이터 없음
